Skip to content

Visual function in retinal degeneration

A cross-sectional study to assess the clinical utility of modern visual function assessments in patients with inherited retinal disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN24016133
Enrollment
80
Registered
2022-08-18
Start date
2021-08-13
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Visual function in patients with inherited retinal disease Eye Diseases

Interventions

There will be two arms to the study. The first arm will include control participants. The second arm will include patient participants with confirmed inherited retinal disease. All participants will u

Sponsors

University of Oxford
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 110 Years

Inclusion criteria

Inclusion criteria: Patient participants: 1. Participant is willing & able to give informed consent for participation in the study. 2. Male or female, aged 16 years or above, there is no upper age limit. 3. An inherited retinal degeneration diagnosis 4. A minimum of 6/60 standard VA in each eye. 5. Able to participate in visual function testing. Control participants: 1. Participant is willing & able to give informed consent for participation in the study. 2. Male or female, aged 16 years or above, there is no upper age limit. 3. A minimum standard VA of 6/7.5 in each eye – this will only become apparent once the participant starts the study, if it is clear they do not meet this criterion, they will be excluded from the study and no further testing undertaken. 4. Able to participate in visual function testing.

Exclusion criteria

Exclusion criteria: Patient participants: 1. Pre-existing amblyopia or squint would exclude that eye, but other eye still eligible 2. History of other eye problems except those relevant to the study, or glasses or contact lenses, if eye problem in just one eye, the other eye is still eligible 3. Been involved in an interventional research trial where they have received a treatment for their eye condition. Control participants: 1. Pre-existing amblyopia or squint, fellow eye still eligible 2. History of eye problems, eye treatment or eye surgery other than glasses or contact lenses, if in one eye, fellow eye still eligible.

Design outcomes

Primary

MeasureTime frame
VIsual function measured at a single time point: 1. Visual acuity 2. Low luminance visual acuity 3. Mesopic microperimetry

Secondary

MeasureTime frame
Visual function measures and visual field tests measured at a single time point: 1. Moorfields Acuity Chart Test 2. Scotopic Microperimetry 3. Low Luminance Questionnaire 4. Obtain qualitative data via semistructured interviews of patient participants in the day following completion of the study tests. The interviews will explore how the tests made the participants feel and whether any changes or improvements can be made to make the tests more acceptable and accessible.

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jun 21, 2026